Improving Participation After Stroke Self-Management-Rehabilitation (IPASS-R)

April 22, 2026 updated by: Anna Boone, University of Missouri-Columbia

Efficacy of the Improving Participation After Stroke Self-Management-Rehabilitation (IPASS-R) Program in Sub-acute Stroke

The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Missouri
      • Columbia, Missouri, United States, 65211
        • Recruiting
        • University of Missouri
        • Contact:
        • Principal Investigator:
          • Anna Boone, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • less than 6 months post-stroke
  • age 45-85 years
  • completed inpatient rehabilitation services (if recommended)
  • living in the community with or without caregiver support (i.e., not living in a skilled nursing facility)
  • ability to read, write, and speak English
  • diagnosis of mild or moderate stroke (National Institutes of Health stroke score <16)
  • able to use videoconferencing independently or with caregiver support

Exclusion Criteria:

  • severe depressive symptoms as indicated by a score ≥21 on the Patient Health Questionnaire
  • dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment
  • additional neurological diagnoses (e.g., brain malignancy, previous severe stroke)
  • (4) moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale aphasia score of ≥ 2
  • inability to provide informed consent
  • any other condition not otherwise specified that the PI determines would render participation in this study as unsafe for the participant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Improving Participation after Stroke Self-Management Program (IPASS)
The IPASS-R intervention consists of 6 weekly 90-minute sessions delivered by an occupational therapist and stroke survivor peer facilitator. All sessions will be delivered remotely via videoconferencing.
The IPASS-R program is a group-based self-management intervention that aims to improve problem-solving, action-planning, and resource utilization skills for improved community living and participation. The Activity-Barriers-Changes-Doing-Evaluation (ABCDE) framework is a user friendly problem-solving and goal setting framework that is used repetitively in each session throughout the program. Participants are guided to identify (1) an activity that they want to improve or re-engage in (A); (2) individual and environmental barriers that hinder their engagement (B); (3) changes that they can make to deal with the barriers and improve their engagement (C); and (4) an action plan to pursue (D). After the action plan, participants come back in the next session and evaluate their performance in following through on their plans (E).
Active Comparator: Chronic Disease Self-Management Program (CDSMP)
The CDSMP will consist of 6, weekly 90-minute sessions. All sessions will be delivered remotely via videoconferencing.
The program is facilitated by two trained leaders in small groups in a community setting with individuals who have chronic health problems and will follow the CDSMP protocol. Participants receive education on various health-related topics applicable to a range of chronic conditions, share experiences, and support one another.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Canadian Occupational Performance Measure (COPM) Performance
Time Frame: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Self-report measure of activity performance. Minimum = 1, Maximum = 10. Higher scores mean better performance.
Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Canadian Occupational Performance Measure (COPM) Satisfaction
Time Frame: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Self-report measure of activity performance. Minimum = 1, Maximum = 10. Higher scores mean higher satisfaction.
Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Participation Strategies Self-Efficacy Scale (PS-SES)
Time Frame: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Self-report measure of self-efficacy in using participation strategies. The subject rates confidence across 35 items within six subscales: (1) managing home participation, (2) staying organized, (3) planning and managing community participation, (4) managing work and productivity), (5) managing communication, and (6) advocating for resources. Range of scores from 35-350. Higher scores indicate greater self-efficacy.
Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
In home activity level as measured by sensor system
Time Frame: Duration of study (from baseline assessment (week 0) to 6-month follow-up assessment)
average hourly percentage of time spent engaged in activity
Duration of study (from baseline assessment (week 0) to 6-month follow-up assessment)
Community engagement as measured by sensor system
Time Frame: Duration of study (from baseline assessment (week 0) to 6-month follow-up assessment)
Time outside the home as measured by time between door sensor activations
Duration of study (from baseline assessment (week 0) to 6-month follow-up assessment)
Stroke Impact Scale participation domain
Time Frame: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Measures perceived stroke recovery/quality of life. Range of scores 0-100. Higher scores indicate higher performance.
Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Assessment of Life Habits (LIFE-H)
Time Frame: Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)
Measures self-reported participation in daily activities by measuring total score across 6 domains. Score range of 0 to 9 with higher scores indicating better performance.
Pre-intervention (week 0), post-intervention (week 6), and 6-month follow-up (week 32)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 16, 2024

Primary Completion (Estimated)

December 15, 2029

Study Completion (Estimated)

December 15, 2029

Study Registration Dates

First Submitted

September 6, 2024

First Submitted That Met QC Criteria

September 6, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

April 28, 2026

Last Update Submitted That Met QC Criteria

April 22, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Improving Participation after Stroke Self-Management Program (IPASS)

Subscribe